Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2010

01.11.2010

A Novel Missense Mutation in the Nuclear Factor-κB Essential Modulator (NEMO) Gene Resulting in Impaired Activation of the NF-κB Pathway and a Unique Clinical Phenotype Presenting as MRSA Subdural Empyema

verfasst von: Gene A. Devora, Lijun Sun, Zhijian Chen, Nicolai S. C. van Oers, Eric P. Hanson, Jordan S. Orange, M. Teresa de la Morena

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

We describe a previously unreported 437 T→G missense mutation producing a V146G substitution in the first coiled-coil (CC1) domain of nuclear factor-κB essential modulator (NEMO) in a 9-month-old boy with ectodermal dysplasia with immunodeficiency who presented with methicillin-resistant Staphylococcus aureus subdural empyema. We performed in vitro experiments to determine if this novel mutation resulted in impaired NF-κB signaling.

Methods

IκBα phosphorylation experiments were performed using a Jurkat T cell line lacking endogenous NEMO expression that was transfected with vectors containing either the wild type or the patient’s V146G mutation. The cells were stimulated with TNF-α to activate the NF-κB pathway. Phosphorylated IκBα was detected by immunoblotting with anti-phospho-IκBα antibodies. Peripheral blood mononuclear cells from the patient were stimulated with TNF-α or anti-CD3 and anti-CD28. Impaired IκBα degradation was detected using antibodies against the IκBα protein.

Results

While TNF-α stimulation resulted in IκBα phosphorylation in NEMO-deficient Jurkat cells reconstituted with wild-type NEMO, cell transfected with the V146G mutant exhibited a 75% reduction in phospho-IκBα. Peripheral blood mononuclear cells from the patient showed impaired degradation of IκBα after stimulation when compared with normal controls.

Conclusions

The patient’s V146G mutation results in impaired NF-κB activation in vitro. The mutation extends the known N-terminal boundary within the CC1 domain that produces an ectodermal dysplasia phenotype, and defines an infectious susceptibility previously unappreciated in ectodermal dysplasia with immunodeficiency (methicillin-resistant S. aureus subdural empyema), broadening the clinical spectrum associated with the disease.
Literatur
1.
Zurück zum Zitat Solt LA, May MJ. The IκB kinase complex: master regulator of NF-κB signaling. Immunol Res. 2008;42:3–18.CrossRefPubMed Solt LA, May MJ. The IκB kinase complex: master regulator of NF-κB signaling. Immunol Res. 2008;42:3–18.CrossRefPubMed
2.
Zurück zum Zitat Gilmore TD. Introduction to NF-κB: players, pathways, perspectives. Oncogene. 2006;25:6680–4.CrossRefPubMed Gilmore TD. Introduction to NF-κB: players, pathways, perspectives. Oncogene. 2006;25:6680–4.CrossRefPubMed
4.
Zurück zum Zitat Scheidereit C. IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene. 2006;25:6685–705.CrossRefPubMed Scheidereit C. IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene. 2006;25:6685–705.CrossRefPubMed
5.
Zurück zum Zitat Puel A, Picard C, Ku C-L, Smahi A, Casanova J-L. Inherited disorders of NF-κB-mediated immunity in man. Curr Opin Immunol. 2004;16:34–41.CrossRefPubMed Puel A, Picard C, Ku C-L, Smahi A, Casanova J-L. Inherited disorders of NF-κB-mediated immunity in man. Curr Opin Immunol. 2004;16:34–41.CrossRefPubMed
6.
7.
Zurück zum Zitat Aggarwal BB. Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745–56.CrossRefPubMed Aggarwal BB. Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745–56.CrossRefPubMed
8.
Zurück zum Zitat Ruland J, Mak TW. Transducing signals from antigen receptors to nuclear factor κB. Immunol Rev. 2003;193:93–100.CrossRefPubMed Ruland J, Mak TW. Transducing signals from antigen receptors to nuclear factor κB. Immunol Rev. 2003;193:93–100.CrossRefPubMed
9.
Zurück zum Zitat Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ, et al. Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122(6):1169–77. e16.CrossRefPubMed Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ, et al. Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122(6):1169–77. e16.CrossRefPubMed
10.
Zurück zum Zitat Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555–62.CrossRefPubMed Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555–62.CrossRefPubMed
11.
Zurück zum Zitat Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat Genet. 2001;27:277–85.CrossRefPubMed Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat Genet. 2001;27:277–85.CrossRefPubMed
12.
Zurück zum Zitat Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2:223–8.CrossRefPubMed Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2:223–8.CrossRefPubMed
13.
Zurück zum Zitat He KL, Ting AT. A20 inhibits tumor necrosis factor (TNF) α-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol. 2002;22:6034–45.CrossRefPubMed He KL, Ting AT. A20 inhibits tumor necrosis factor (TNF) α-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol. 2002;22:6034–45.CrossRefPubMed
14.
Zurück zum Zitat Pandey R, Destephan CM, Madge LA, May MJ, Orange JS. NKp30 ligation induces rapid activation of the canonical NF-κB pathway in NK cells. J Immunol. 2007;179:7385–96.PubMed Pandey R, Destephan CM, Madge LA, May MJ, Orange JS. NKp30 ligation induces rapid activation of the canonical NF-κB pathway in NK cells. J Immunol. 2007;179:7385–96.PubMed
15.
Zurück zum Zitat Orange JS, Levy O, Brodeur SR, Krzewski K, Roy RM, Niemela JE, et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol. 2004;114(3):650–6.CrossRefPubMed Orange JS, Levy O, Brodeur SR, Krzewski K, Roy RM, Niemela JE, et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol. 2004;114(3):650–6.CrossRefPubMed
Metadaten
Titel
A Novel Missense Mutation in the Nuclear Factor-κB Essential Modulator (NEMO) Gene Resulting in Impaired Activation of the NF-κB Pathway and a Unique Clinical Phenotype Presenting as MRSA Subdural Empyema
verfasst von
Gene A. Devora
Lijun Sun
Zhijian Chen
Nicolai S. C. van Oers
Eric P. Hanson
Jordan S. Orange
M. Teresa de la Morena
Publikationsdatum
01.11.2010
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9445-y

Weitere Artikel der Ausgabe 6/2010

Journal of Clinical Immunology 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.